First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK
First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Integrin-targeting radiopharmaceuticals have potential broad applications, spanning from cancer theranostics to cardiovascular diseases. We have previously reported preclinical dosimetry results of
68
Ga-NODAGA-RGDyK in mice. This study presents the first human dosimetry of
68
Ga-NODAGA-RGDyK in the five consecutive patien...
Alternative Titles
Full title
First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_57fdd9a8d4644ce6a32447c324ae07bb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_57fdd9a8d4644ce6a32447c324ae07bb
Other Identifiers
ISSN
2191-219X
E-ISSN
2191-219X
DOI
10.1186/s13550-017-0288-x
